Radiation-induced delayed cell death in a hypomorphic Artemis cell line

被引:34
作者
Evans, PM
Woodbine, L
Riballo, E
Gennery, AR
Hubank, M
Jeggo, PA
机构
[1] UCL, Inst Child Hlth, London WC1N 1EH, England
[2] Univ Sussex, Genome Damage & Stabil Ctr, Brighton BN1 9RQ, E Sussex, England
[3] Newcastle Gen Hosp, Dept Pediat Immunol, Newcastle Upon Tyne NE4 6BE, Tyne & Wear, England
基金
英国医学研究理事会;
关键词
D O I
10.1093/hmg/ddl050
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Null mutations in Artemis confer a condition described as RS-SCID, in which patients display radiosensitivity combined with severe combined immunodeficiency. Here, we characterize the defect in Artemis in a patient who displayed progressive combined immunodeficiency (CID) and elevated lymphocyte apoptosis. The patient is a compound heterozygote with novel mutations in both alleles, resulting in Artemis proteins with either L70 deletion or G126D substitution. Both mutational changes impact upon Artemis function and a fibroblast cell line derived from the patient (F96-224) has greatly reduced Artemis protein. In contrast to Artemis null cell lines, which fail to repair a subset of DNA double strand breaks (DSBs) induced by ionizing radiation, F96-224 cells show slow but residual DSB rejoining. Despite showing intermediate cellular and clinical features, F96-224 cells are as radiosensitive as Artemis null cell lines. We developed a FACS-based assay to examine cell division and cellular characteristics for 10 days following exposure to ionizing radiation (2 and 4 Gy). This analysis demonstrated that F96-224 cells show delayed cell death when compared with rapid growth arrest of an Artemis null cell line, and the emergence of a cycling population shown by a control line. F96-224 cells also display elevated chromosome aberrations when compared with control cells. F96-224 therefore represents a novel phenotype for a hypomorphic cell line. We suggest that delayed cell death contributes to the progressive CID phenotype of the Artemis patient.
引用
收藏
页码:1303 / 1311
页数:9
相关论文
共 22 条
[1]   Omenn syndrome due to ARTEMIS mutations [J].
Ege, M ;
Ma, YM ;
Manfras, B ;
Kalwak, K ;
Lu, HH ;
Lieber, MR ;
Schwarz, K ;
Pannicke, U .
BLOOD, 2005, 105 (11) :4179-4186
[2]   V(D)J recombination: RAG proteins, repair factors, and regulation [J].
Gellert, M .
ANNUAL REVIEW OF BIOCHEMISTRY, 2002, 71 :101-132
[3]  
Jeggo PA, 2004, MOL B INT U, P146
[4]   Novel Artemis gene mutations of radiosensitive severe combined immunodeficiency in Japanese families [J].
Kobayashi, N ;
Agematsu, K ;
Sugita, K ;
Sako, M ;
Nonoyama, S ;
Yachie, A ;
Kumaki, S ;
Tsuchiya, S ;
Ochs, HD ;
Sugita, K ;
Fukushima, Y ;
Komiyama, A .
HUMAN GENETICS, 2003, 112 (04) :348-352
[5]   A double-strand break repair defect in ATM-deficient cells contributes to radiosensitivity [J].
Kühne, M ;
Riballo, E ;
Rief, N ;
Rothkamm, K ;
Jeggo, PA ;
Löbrich, M .
CANCER RESEARCH, 2004, 64 (02) :500-508
[6]   Harmonising the response to DSBs:: a new string in the ATM bow [J].
Löbrich, M ;
Jeggo, PA .
DNA REPAIR, 2005, 4 (07) :749-759
[7]   Analysing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution [J].
Lyons, AB .
JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 243 (1-2) :147-154
[8]   Hairpin opening and overhang processing by an Artemis/DNA-dependent protein kinase complex in nonhomologous end joining and V(D)J recombination [J].
Ma, YM ;
Pannicke, U ;
Schwarz, K ;
Lieber, MR .
CELL, 2002, 108 (06) :781-794
[9]   Artemis, a novel DNA double-strand break repair/V(D)J recombination protein, is mutated in human severe combined immune deficiency [J].
Moshous, D ;
Callebaut, I ;
de Chasseval, R ;
Corneo, B ;
Cavazzana-Calvo, M ;
Le Deist, F ;
Tezcan, I ;
Sanal, O ;
Bertrand, Y ;
Philippe, N ;
Fischer, A ;
de Villartay, JP .
CELL, 2001, 105 (02) :177-186
[10]   Partial T and B lymphocyte immunodeficiency and predisposition to lymphoma in patients with hypomorphic mutations in Artemis [J].
Moshous, D ;
Pannetier, C ;
de Chasseval, R ;
le Deist, F ;
Cavazzana-Calvo, M ;
Romana, S ;
Macintyre, E ;
Canioni, D ;
Brousse, N ;
Fischer, A ;
Casanova, JL ;
de Villartay, JP .
JOURNAL OF CLINICAL INVESTIGATION, 2003, 111 (03) :381-387